{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:19:43Z","timestamp":1779297583590,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA154786"],"award-info":[{"award-number":["R21 CA154786"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA198495"],"award-info":[{"award-number":["R21 CA198495"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016087"],"award-info":[{"award-number":["P30 CA016087"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA225450"],"award-info":[{"award-number":["P50 CA225450"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["UO1 FD004203"],"award-info":[{"award-number":["UO1 FD004203"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jid.2020.01.027","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:46:53Z","timestamp":1582166813000},"page":"1609-1618.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-5367","authenticated-orcid":false,"given":"Gregory A.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-2299","authenticated-orcid":false,"given":"Jennifer M.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-1803","authenticated-orcid":false,"given":"Broderick C.","family":"Corless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4081-2068","authenticated-orcid":false,"given":"Mahrukh M.","family":"Syeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-1825","authenticated-orcid":false,"given":"Jyothirmayee S.","family":"Tadepalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1397-9900","authenticated-orcid":false,"given":"Shria","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8130-9189","authenticated-orcid":false,"given":"Nathaniel","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-1982","authenticated-orcid":false,"given":"Farbod","family":"Darvishian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7088-0742","authenticated-orcid":false,"given":"Anna","family":"Pavlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5026-5651","authenticated-orcid":false,"given":"Russell","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-4751","authenticated-orcid":false,"given":"Richard","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-6755","authenticated-orcid":false,"given":"Yongzhao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-3561","authenticated-orcid":false,"given":"George","family":"Karlin-Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-4822","authenticated-orcid":false,"given":"Cindy","family":"Spittle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-1971","authenticated-orcid":false,"given":"Iman","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9554-5289","authenticated-orcid":false,"given":"David","family":"Polsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.01.027_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.01.027_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejca.2012.08.018","article-title":"18)F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma","volume":"49","author":"Carlino","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2020.01.027_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12916-017-0900-y","article-title":"The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome","volume":"15","author":"Caswell","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jid.2020.01.027_bib4","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl. 13","key":"10.1016\/j.jid.2020.01.027_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/1538-7445.AM2017-743","article-title":"Detection of TERT C228T and C250T promoter mutations in melanoma tumor and plasma samples using novel mutation-specific droplet digital PCR assays","volume":"77","author":"Corless","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.01.027_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmoldx.2018.09.003","article-title":"Development of novel mutation-specific droplet digital PCR assays detecting tert promoter mutations in tumor and plasma samples","volume":"21","author":"Corless","year":"2019","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jid.2020.01.027_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2017.01.003","article-title":"Tumor evolution: linear, branching, neutral or punctuated?","volume":"1867","author":"Davis","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jid.2020.01.027_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1373\/clinchem.2014.223040","article-title":"Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization","volume":"61","author":"Do","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jid.2020.01.027_bib9","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-15-3476","article-title":"Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma","volume":"76","author":"Harbst","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.01.027_bib10","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.01.027_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.15252\/emmm.201404914","article-title":"Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts","volume":"7","author":"Kemper","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jid.2020.01.027_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.bjc.6606072","article-title":"Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression","volume":"104","author":"Lin","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2020.01.027_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrc.2017.69","article-title":"Classifying the evolutionary and ecological features of neoplasms","volume":"17","author":"Maley","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2020.01.027_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","author":"McGranahan","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.01.027_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jid.2020.01.027_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085004","article-title":"Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma","volume":"9","author":"Menzies","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2020.01.027_bib17","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/bjc.2013.796","article-title":"Intra-patient heterogeneity of BRAF mutation status: fact or fiction?","volume":"111","author":"Menzies","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2020.01.027_bib18","doi-asserted-by":"crossref","first-page":"77163","DOI":"10.18632\/oncotarget.12848","article-title":"Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance","volume":"7","author":"Raaijmakers","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.01.027_bib19","first-page":"291","article-title":"Controversies in intrapatient melanoma BRAFV600E mutation status","volume":"39","author":"Riveiro-Falkenbach","year":"2017","journal-title":"Am J Derm Pathol"},{"key":"10.1016\/j.jid.2020.01.027_bib20","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1073\/pnas.1508074112","article-title":"Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination","volume":"112","author":"Sanborn","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2020.01.027_bib21","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.onc.1209379","article-title":"Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma","volume":"25","author":"Sensi","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.01.027_bib22","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.01.027_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","article-title":"Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy","volume":"4","author":"Shi","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2020.01.027_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-9773-2_7","article-title":"Validation of circulating tumor DNA assays for detection of metastatic melanoma","volume":"2055","author":"Syeda","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jid.2020.01.027_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/JID.2015.348","article-title":"BRAFV600E and NRASQ61R homogeneity in melanoma tumors","volume":"136","author":"Uguen","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.01.027_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.05.015","article-title":"Discrepancy in BRAF status among patients with metastatic malignant melanoma: a meta-analysis","volume":"81","author":"Valachis","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2020.01.027_bib27","doi-asserted-by":"crossref","first-page":"a026617","DOI":"10.1101\/cshperspect.a026617","article-title":"Treatment-induced mutagenesis and selective pressures sculpt cancer evolution","volume":"7","author":"Venkatesan","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jid.2020.01.027_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaad.2018.09.030","article-title":"The role of tert promoter mutations in differentiating recurrent nevi from recurrent melanomas: a retrospective, case-control study","volume":"80","author":"Walton","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.01.027_bib29","first-page":"35","article-title":"Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research","volume":"1","author":"Wich","year":"2009","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jid.2020.01.027_bib30","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1535-7163.MCT-12-0530","article-title":"Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine","volume":"11","author":"Wilmott","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2020.01.027_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029336","article-title":"Intra- and inter-tumor heterogeneity of BRAF(V600E)mutations in primary and metastatic melanoma","volume":"7","author":"Yancovitz","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20301597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20301597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:43:55Z","timestamp":1762206235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20301597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0022202X20301597"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.01.027","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}